The Market Reports

Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com

Global Desensitization Therapy Market Research Report 2024

Global Desensitization Therapy Market Research Report 2024

Publishing Date : Aug, 2023

License Type :
 

Report Code : 1767220

No of Pages : 82

Synopsis
Desensitization or hypo-sensitization, is a medical treatment for some types of allergies. It is useful for environmental allergies, allergies to insect bites, and asthma. Its benefit for food allergies is unclear and thus not recommended. Immunotherapy involves exposing people to larger and larger amounts of allergen in an attempt to change the immune system's response.

Global Desensitization Therapy market is projected to reach US$ 2546.7 million in 2029, increasing from US$ 1586 million in 2022, with the CAGR of 7.0% during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole Desensitization Therapy market research.

The market driver for Desensitization Treatment is the increasing prevalence of allergies and the growing need for effective allergy management. Desensitization treatment, also known as immunotherapy, offers a potential cure for allergies by reducing sensitivity to allergens. Rising awareness of the treatment's benefits and advancements in allergy research contribute to market growth. However, challenges include the lengthy treatment duration, potential side effects, and the need for personalized treatment plans. Additionally, reimbursement issues and the availability of alternative allergy management options may pose challenges for market adoption. Despite challenges, the Desensitization Treatment market presents opportunities for improved patient outcomes and better quality of life for individuals with allergies, driving further research and innovation in allergy care.

Report Scope

This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global Desensitization Therapy market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.

By Company

  • ALK-Abello
  • Stallergenes Greer
  • Merck
  • Allergy Therapeutics
  • WOLW Pharma
  • HAL
  • Holister Stier
  • Leti

Segment by Type

  • Subcutaneous Immunotherapy
  • Sublingual Immunotherapy

Segment by Application

  • Allergic Rhinitis
  • Allergic Asthma
  • Other

By Region

  • North America (United States, Canada)
  • Europe (Germany, France, U.K., Italy, Russia, Nordic Countries, Rest of Europe)
  • Asia-Pacific (China, Japan, South Korea,Southeast Asia, India, Australia, Rest of Asia)
  • Latin America (Mexico, Brazil, Rest of Latin America)
  • Middle East & Africa (Turkey, Saudi Arabia, UAE, Rest of MEA)

The Desensitization Therapy report covers below items:

Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies' Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source

Index

1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global Desensitization Therapy Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 Subcutaneous Immunotherapy
1.2.3 Sublingual Immunotherapy
1.3 Market by Application
1.3.1 Global Desensitization Therapy Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Allergic Rhinitis
1.3.3 Allergic Asthma
1.3.4 Other
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global Desensitization Therapy Market Perspective (2018-2029)
2.2 Desensitization Therapy Growth Trends by Region
2.2.1 Global Desensitization Therapy Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 Desensitization Therapy Historic Market Size by Region (2018-2023)
2.2.3 Desensitization Therapy Forecasted Market Size by Region (2024-2029)
2.3 Desensitization Therapy Market Dynamics
2.3.1 Desensitization Therapy Industry Trends
2.3.2 Desensitization Therapy Market Drivers
2.3.3 Desensitization Therapy Market Challenges
2.3.4 Desensitization Therapy Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top Desensitization Therapy Players by Revenue
3.1.1 Global Top Desensitization Therapy Players by Revenue (2018-2023)
3.1.2 Global Desensitization Therapy Revenue Market Share by Players (2018-2023)
3.2 Global Desensitization Therapy Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by Desensitization Therapy Revenue
3.4 Global Desensitization Therapy Market Concentration Ratio
3.4.1 Global Desensitization Therapy Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by Desensitization Therapy Revenue in 2022
3.5 Desensitization Therapy Key Players Head office and Area Served
3.6 Key Players Desensitization Therapy Product Solution and Service
3.7 Date of Enter into Desensitization Therapy Market
3.8 Mergers & Acquisitions, Expansion Plans
4 Desensitization Therapy Breakdown Data by Type
4.1 Global Desensitization Therapy Historic Market Size by Type (2018-2023)
4.2 Global Desensitization Therapy Forecasted Market Size by Type (2024-2029)
5 Desensitization Therapy Breakdown Data by Application
5.1 Global Desensitization Therapy Historic Market Size by Application (2018-2023)
5.2 Global Desensitization Therapy Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America Desensitization Therapy Market Size (2018-2029)
6.2 North America Desensitization Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America Desensitization Therapy Market Size by Country (2018-2023)
6.4 North America Desensitization Therapy Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe Desensitization Therapy Market Size (2018-2029)
7.2 Europe Desensitization Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe Desensitization Therapy Market Size by Country (2018-2023)
7.4 Europe Desensitization Therapy Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific Desensitization Therapy Market Size (2018-2029)
8.2 Asia-Pacific Desensitization Therapy Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific Desensitization Therapy Market Size by Region (2018-2023)
8.4 Asia-Pacific Desensitization Therapy Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America Desensitization Therapy Market Size (2018-2029)
9.2 Latin America Desensitization Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America Desensitization Therapy Market Size by Country (2018-2023)
9.4 Latin America Desensitization Therapy Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa Desensitization Therapy Market Size (2018-2029)
10.2 Middle East & Africa Desensitization Therapy Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa Desensitization Therapy Market Size by Country (2018-2023)
10.4 Middle East & Africa Desensitization Therapy Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 ALK-Abello
11.1.1 ALK-Abello Company Detail
11.1.2 ALK-Abello Business Overview
11.1.3 ALK-Abello Desensitization Therapy Introduction
11.1.4 ALK-Abello Revenue in Desensitization Therapy Business (2018-2023)
11.1.5 ALK-Abello Recent Development
11.2 Stallergenes Greer
11.2.1 Stallergenes Greer Company Detail
11.2.2 Stallergenes Greer Business Overview
11.2.3 Stallergenes Greer Desensitization Therapy Introduction
11.2.4 Stallergenes Greer Revenue in Desensitization Therapy Business (2018-2023)
11.2.5 Stallergenes Greer Recent Development
11.3 Merck
11.3.1 Merck Company Detail
11.3.2 Merck Business Overview
11.3.3 Merck Desensitization Therapy Introduction
11.3.4 Merck Revenue in Desensitization Therapy Business (2018-2023)
11.3.5 Merck Recent Development
11.4 Allergy Therapeutics
11.4.1 Allergy Therapeutics Company Detail
11.4.2 Allergy Therapeutics Business Overview
11.4.3 Allergy Therapeutics Desensitization Therapy Introduction
11.4.4 Allergy Therapeutics Revenue in Desensitization Therapy Business (2018-2023)
11.4.5 Allergy Therapeutics Recent Development
11.5 WOLW Pharma
11.5.1 WOLW Pharma Company Detail
11.5.2 WOLW Pharma Business Overview
11.5.3 WOLW Pharma Desensitization Therapy Introduction
11.5.4 WOLW Pharma Revenue in Desensitization Therapy Business (2018-2023)
11.5.5 WOLW Pharma Recent Development
11.6 HAL
11.6.1 HAL Company Detail
11.6.2 HAL Business Overview
11.6.3 HAL Desensitization Therapy Introduction
11.6.4 HAL Revenue in Desensitization Therapy Business (2018-2023)
11.6.5 HAL Recent Development
11.7 Holister Stier
11.7.1 Holister Stier Company Detail
11.7.2 Holister Stier Business Overview
11.7.3 Holister Stier Desensitization Therapy Introduction
11.7.4 Holister Stier Revenue in Desensitization Therapy Business (2018-2023)
11.7.5 Holister Stier Recent Development
11.8 Leti
11.8.1 Leti Company Detail
11.8.2 Leti Business Overview
11.8.3 Leti Desensitization Therapy Introduction
11.8.4 Leti Revenue in Desensitization Therapy Business (2018-2023)
11.8.5 Leti Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details

Published By : QY Research

Why ‘The Market Reports’